Clinical trial NCT05098691: Early Onset Preeclampsia and Nectin-4
Official title: Serum Nectin-4 Levels in Patients With Early Onset Preeclampsia
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Pre-Eclampsia
Early Onset Preeclampsia
Oxidative Stress
Immunologic Diseases in Pregnancy
Keywords: early onset preeclampsia
nectin-4
advers pregnancy outcome
hypertansion
Lead sponsor: Kayseri Education and Research Hospital
Sponsor class: OTHER_GOV
First posted: 2021-10-28
Enrollment: 84
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Comparison to the level of soluble nectin-4 in early-onset PE, compared to healthy pregnancies

Brief summary: Early-onset Preeclampsia (PE) is a pregnancy disorder which may present with adverse pregnancy outcomes. Nectin-4 is an adhesion molecule mainly expressed in placenta. This study aimed to evaluate the relationship between early onset Preeclampsia and serum Nectin 4 levels.

Detailed description: Preeclampsia is assumed as a two-stage disorder arising from defective trophoblast invasion and failure of spiral artery remodeling as the main step responsible for the pathogenesis. PE is classified according to the disease onset time as early-onset PE before 34 weeks and late-onset PE after 34 weeks. Late-onset PE is more commonly seen and accepted as a mild maternal reaction to pregnancy. In early-onset PE, unlike the late-onset, due to the improper placental invasion, the diffuse placental ischemia and the resulting oxidative stress begin at early gestation. Thus, the early-onset PE may result in severe disease leading to perinatal and maternal morbidity and mortality.

The nectins are calcium-independent immunoglobulin-like celladhesion molecules and have a pivotal role at cellular junctions, as well as physiological regulations(8). Placenta expressesfor types of nectins; nectin-1, nectin-2, nectin-3, and nectin-4. They are localized at tight junctions and gap junctions of syncitiotrophoblasts(9). Nectin-4 is a relatively novel member of nectin family which has been detected only in placenta and airway epithelium in healthy subjects.

Despite, there has been no study published yet to reveal the soluble nectin-4 levels in preeclampsia as well as in early onset disease. In this study, we aimed to investigate the serum nectin-4 levels in early-onset preeclampsia in comparison of the healthy pregnancies.

Eligibility criteria: Inclusion Criteria:

* spontaneous,
* singleton pregnancies
* above the 24 weeks of gestations
* positive fetal cardiac activity

Exclusion Criteria:

* multiple gestations,
* chronic hypertension
* hypothyroidism
* known malignancy,- diabetes mellitus,
* presence of fetal or maternal infection,
* clinical signs of chorioamnionitis (maternal fever, vaginal discharge, fetal tachycardia),
* hepatic or renal failure
* Placenta previa or pregnancies accompanied congenital fetal abnormalities or aneuploidies

Primary outcomes:
measure: serum nectin-4 levels
timeFrame: 1 hour
Secondary outcomes:
measure: BMI (body mass index)
timeFrame: 5 minute
measure: Tansion Arterial
timeFrame: 5 minute
Other outcomes:
Locations:
city: İstanbul
country: Turkey
facility: Hatice Akkaya
Study officials:
References: